364 related articles for article (PubMed ID: 18158579)
1. Detection of CD55- and CD59-deficient granulocytic populations in patients with myelodysplastic syndrome.
Kaiafa G; Papadopoulos A; Ntaios G; Saouli Z; Savopoulos C; Tsesmeli N; Kontoninas Z; Chatzinikolaou A; Tsavdaridou V; Klonizakis I; Hatzitolios A
Ann Hematol; 2008 Apr; 87(4):257-62. PubMed ID: 18158579
[TBL] [Abstract][Full Text] [Related]
2. [Expression of three kinds of GPI-anchor proteins in paroxysmal nocturnal hemoglobinuria, aplastic anemia and myelodysplastic syndromes patients and their clinical implications].
Dong XY; Xu CG; Sun GR; Zhang T; Peng J
Zhonghua Xue Ye Xue Za Zhi; 2004 Apr; 25(4):198-201. PubMed ID: 15182554
[TBL] [Abstract][Full Text] [Related]
3. A cohort study of the nature of paroxysmal nocturnal hemoglobinuria clones and PIG-A mutations in patients with aplastic anemia.
Wanachiwanawin W; Siripanyaphinyo U; Piyawattanasakul N; Kinoshita T
Eur J Haematol; 2006 Jun; 76(6):502-9. PubMed ID: 16529603
[TBL] [Abstract][Full Text] [Related]
4. [Studies on the expression of complement regulatory proteins in three kinds of stem cell defect anemias and its clinical implications].
Xu C; Zhang T; Zhao R
Zhonghua Xue Ye Xue Za Zhi; 1999 Oct; 20(10):511-4. PubMed ID: 11721394
[TBL] [Abstract][Full Text] [Related]
5. Differential usefulness of various markers in the flow cytometric detection of paroxysmal nocturnal hemoglobinuria in blood and bone marrow.
Olteanu H; Karandikar NJ; McKenna RW; Xu Y
Am J Clin Pathol; 2006 Nov; 126(5):781-8. PubMed ID: 17050075
[TBL] [Abstract][Full Text] [Related]
6. Abnormalities in the expression of CD55 and CD59 surface molecules on peripheral blood cells are not specific to paroxysmal nocturnal hemoglobinuria.
Ruiz-Delgado GJ; Vázquez-Garza E; Méndez-Ramírez N; Gómez-Almaguer D
Hematology; 2009 Feb; 14(1):33-7. PubMed ID: 19154662
[TBL] [Abstract][Full Text] [Related]
7. [Detection of PNH clones using flow cytometry in aplastic anemia and paroxysmal nocturnal hemoglobinuria].
Forés R; Alcocer M; Cabrera R; Sanjuán I; Briz M; Lago C; Fernández MN
Sangre (Barc); 1999 Jun; 44(3):199-203. PubMed ID: 10481581
[TBL] [Abstract][Full Text] [Related]
8. Use of a FLAER-based WBC assay in the primary screening of PNH clones.
Sutherland DR; Kuek N; Azcona-Olivera J; Anderson T; Acton E; Barth D; Keeney M
Am J Clin Pathol; 2009 Oct; 132(4):564-72. PubMed ID: 19762534
[TBL] [Abstract][Full Text] [Related]
9. Detailed immunophenotypic characterization of different major and minor subsets of peripheral blood cells in patients with paroxysmal nocturnal hemoglobinuria.
Hernández-Campo PM; Almeida J; Acevedo MJ; Sánchez ML; Alberca I; Vidriales B; Martínez E; Romero JR; Orfao A
Transfusion; 2008 Jul; 48(7):1403-14. PubMed ID: 18422849
[TBL] [Abstract][Full Text] [Related]
10. Quantitation of CD55 and CD59 expression on reticulocytes and mature erythrocytes in paroxysmal nocturnal hemoglobinuria, aplastic anemia, and healthy control subjects.
Kim Y; Lim J; Kim M; Kim Y; Lee JW; Han K
Ann Clin Lab Sci; 2010; 40(3):226-32. PubMed ID: 20689133
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric analysis of CD55 and CD59 expression on blood cells in paroxysmal nocturnal haemoglobinuria.
Dworacki G; Sikora J; Mizera-Nyczak E; Trybus M; Mozer-Lisewska I; Czyz A; Zeromski J
Folia Histochem Cytobiol; 2005; 43(2):117-20. PubMed ID: 16044949
[TBL] [Abstract][Full Text] [Related]
12. Reduction of CD55 and/or CD59 in red blood cells of patients with HIV infection.
Terpos E; Sarantopoulos A; Kouramba A; Katsarou O; Stavropoulos J; Masouridi S; Karafoulidou A; Meletis J
Med Sci Monit; 2008 May; 14(5):CR276-280. PubMed ID: 18443552
[TBL] [Abstract][Full Text] [Related]
13. Levels of soluble forms of ICAM and VCAM in patients with myelodysplastic syndromes and their prognostic significance.
Passam FH; Tsirakis G; Boula A; Fragou A; Consolas I; Alegakis A; Kyriakou DS; Alexandrakis MG
Clin Lab Haematol; 2004 Dec; 26(6):391-5. PubMed ID: 15595996
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of a minor population of paroxysmal nocturnal hemoglobinuria-type cells in bone marrow failure syndrome.
Wang H; Chuhjo T; Yasue S; Omine M; Nakao S
Blood; 2002 Dec; 100(12):3897-902. PubMed ID: 12393738
[TBL] [Abstract][Full Text] [Related]
15. Detection of small populations of CD59-deficient erythrocytes in patients with aplastic anemia or myelodysplastic syndrome and normal individuals.
Yamaguchi M; Machii T; Azenishi Y; Nishimura J; Shibano M; Kanakura Y; Kitani T
Blood Cells Mol Dis; 2000 Jun; 26(3):247-54. PubMed ID: 10950945
[TBL] [Abstract][Full Text] [Related]
16. Expression of CD59 on lymphocyte and the subsets and its potential clinical application for paroxysmal nocturnal hemoglobinuria diagnosis.
Cui W; Fan Y; Yang M; Zhang Z
Clin Lab Haematol; 2004 Apr; 26(2):95-100. PubMed ID: 15053802
[TBL] [Abstract][Full Text] [Related]
17. Detection of paroxysmal nocturnal hemoglobinuria-phenotype in patients with chronic lymphocytic leukemia and multiple myeloma.
Varma S; Varma N; Reddy VV; Naseem S; Bose P; Malhotra P
Indian J Pathol Microbiol; 2012; 55(2):206-10. PubMed ID: 22771645
[TBL] [Abstract][Full Text] [Related]
18. [Study on prognostic factors in twenty-five patients with myelodysplastic syndrome].
Toyama T; Uno H; Yamashita K; Kubuki Y; Suzuki M; Maeda K; Matsuoka H; Tsubouchi H
Gan To Kagaku Ryoho; 1995 Feb; 22(2):227-32. PubMed ID: 7857097
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of paroxysmal nocturnal hemoglobinuria in Chinese patients with Budd-Chiari syndrome or portal vein thrombosis.
Qi X; He C; Han G; Yin Z; Wu F; Zhang Q; Niu J; Wu K; Fan D
J Gastroenterol Hepatol; 2013 Jan; 28(1):148-52. PubMed ID: 23020629
[TBL] [Abstract][Full Text] [Related]
20. [Retrospective analysis of hemotherapy support in 226 cases of myelodysplastic syndromes].
Rubio-Félix D; Franco E; Giraldo P; Gimeno J; Cuesta I; Giralt M
Sangre (Barc); 1994 Apr; 39(2):117-20. PubMed ID: 8059289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
